No
from Section V - Cervical Cancer
Published online by Cambridge University Press: 20 July 2023
Cervical cancer is the fourth most commonly diagnosed and one of the deadliest cancers in women worldwide. There is an urgent need for more active treatments and rationally designed targeted therapies for advanced disease. Recently, immunotherapy has been proven to be effective in several solid tumors. There are few phase I/II studies in advanced or recurrent cervical cancer patients, no quality of life analysis in the studies, limited objective responses, and no clear superiority over second-line chemotherapy, but certainly more expense. Therefore, currently there is no role of immunotherapy in treatment of cervical cancer.
To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.